Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
PLoS One. 2018 Mar 29;13(3):e0195086. doi: 10.1371/journal.pone.0195086. eCollection 2018.
Type 2 Diabetes Mellitus (T2DM) is reported to affect one in 11 adults worldwide, with over 80% of T2DM patients residing in low-to-middle-income countries. Health systems play an integral role in responding to this increasing global prevalence, and are key to ensuring effective diabetes management. We conducted a systematic review to examine the health system-level factors influencing T2DM awareness, treatment, adherence, and control.
A protocol for this study was published on the PROSPERO international prospective register of systematic reviews (PROSPERO 2016: CRD42016048185). Studies included in this review reported the effects of health systems factors, interventions, policies, or programmes on T2DM control, awareness, treatment, and adherence. The following databases were searched on 22 February 2017: Medline, Embase, Global health, LILACS, Africa-Wide, IMSEAR, IMEMR, and WPRIM. There were no restrictions on date, language, or study designs. Two reviewers independently screened studies for eligibility, extracted the data, and screened for risk of bias. Thereafter, we performed a narrative synthesis. A meta-analysis was not conducted due to methodological heterogeneity across different aspects of included studies. 93 studies were included for qualitative synthesis; 7 were conducted in LMICs. Through this review, we found two key health system barriers to effective T2DM care and management: financial constraints faced by the patient and limited access to health services and medication. We also found three health system factors that facilitate effective T2DM care and management: the use of innovative care models, increased pharmacist involvement in care delivery, and education programmes led by healthcare professionals.
This review points to the importance of reducing, or possibly eliminating, out-of-pocket costs for diabetes medication and self-monitoring supplies. It also points to the potential of adopting more innovative and integrated models of care, and the value of task-sharing of care with pharmacists. More studies which identify the effect of health system arrangements on various outcomes, particularly awareness, are needed.
据报道,全球每 11 个成年人中就有 1 人患有 2 型糖尿病(T2DM),其中超过 80%的 T2DM 患者居住在中低收入国家。卫生系统在应对这一不断增加的全球患病率方面发挥着重要作用,是确保有效糖尿病管理的关键。我们进行了一项系统评价,以研究影响 T2DM 知晓率、治疗、依从性和控制的卫生系统因素。
该研究的方案已在 PROSPERO 国际前瞻性系统评价注册库(PROSPERO 2016:CRD42016048185)上发表。本综述纳入的研究报告了卫生系统因素、干预措施、政策或方案对 T2DM 控制、知晓率、治疗和依从性的影响。于 2017 年 2 月 22 日检索了以下数据库:Medline、Embase、全球健康、LILACS、Africa-Wide、IMSEAR、IMEMR 和 WPRIM。研究没有对日期、语言或研究设计进行限制。两名审查员独立筛选研究的合格性、提取数据并筛选偏倚风险。之后,我们进行了叙述性综合分析。由于纳入研究的不同方面存在方法学异质性,因此未进行荟萃分析。纳入 93 项研究进行定性综合分析;其中 7 项在中低收入国家开展。通过本次综述,我们发现影响有效 T2DM 护理和管理的两个关键卫生系统障碍:患者面临的财务限制以及获取卫生服务和药物的有限性。我们还发现促进有效 T2DM 护理和管理的三个卫生系统因素:采用创新的护理模式、增加药剂师在护理提供中的参与度以及由医疗保健专业人员主导的教育计划。
本综述强调了降低(或可能消除)糖尿病药物和自我监测用品自付费用的重要性。它还指出了采用更具创新性和综合性的护理模式以及与药剂师分担护理任务的潜力。需要更多研究来确定卫生系统安排对各种结果(特别是知晓率)的影响。